About nanoMAG

nanoMAG^® LLC, a medical device and engineered biomaterials manufacturer, is developing and commercializing its bioabsorbable BioMg^® alloy for Craniomaxillofacial implant applications. By using a bioabsorbable metal alloy designed specifically for temporary implants, our devices provide adequate reinforcement while avoiding complications associated with current implants made of permanent metal alloys and bioabsorbable polymers.

Although our primary focus is the Craniomaxillofacial implant market, we have opportunities across many biomedical applications, which include various orthopedic, dental, and vascular devices.

magnesium alloy plate for dental application

nanoMAG development projects have been sponsored by the following contracts:

National Institutes of Health – Phase II SBIR on BioMg^® Mandible Fixation
National Institutes of Health – Regenerative Medicine Resource Center: University of Pittsburgh, University of Michigan, Harvard Wyss Institute
National Science Foundation – STTR grant 0637203 with University of Michigan and North Carolina A&T

nanoMAG^® LLC is a subsidiary of Thixomat Technologies LLC, a company with more than 25 years’ experience in the research, development and marketing of technologies for the manufacturing of products utilizing magnesium alloys.

nanoMAG is comprised of the same team that led the successful global business of Thixomat, resulting in more than 50 Thixomat licenses in 13 countries globally.

Building on the 25-year success of Thixomat, which pioneered injection molding of light-weight, high-strength magnesium alloys and components, nanoMAG was created to commercialize the proprietary BioMg^® technology developed with the University of Michigan. Our magnesium technology experts have teamed with professionals from the medical technology and healthcare industries to commercialize BioMg^®.

nanoMAG has executed its first BioMg^® commercial license for specific applications with Magnesium Development Company (MDC). Through this exclusive worldwide license, MDC is developing BioMg^® interference screws for anterior cruciate ligament (ACL) repair, along with other applications in knee and shoulder sports medicine, and foot and ankle fixation.

How We Work

nanoMAG has highly skilled and innovative people with experience in magnesium alloy and medical device design, development, and manufacturing. Through strategic partnerships with medical device manufacturers, researchers, and universities, nanoMAG is bringing to market a new generation of medical devices.

Management Team

The management team for nanoMAG consists of experienced business and technical professionals complemented by CMF Medical Advisory Board and a Board of Directors.

Stephen Lebeau — **Stephen LeBeau**, PhD
*President*

Serial Entrepreneur in advanced materials, 3 firms, 25 years

**Anthony Melkent**, BS, MBA
Vice President
Product Development and Quality

Medical Device Product Development, Medtronic, Wright Medical, Smith & Nephew, 25 years

**Raymond Decker**, PhD
*Chief Technology Officer*

Serial Entrepreneur in advanced materials, 3 firms, 25 years; Member, National Academy of Engineering

CMF Medical Advisory Board

**Kevin McLeod**
*CMF Medical Advisory Board*

Former BD, Stryker Medical CMF, 25 years Global Business Development

**Robert Ronk**,
*CMF Medical Advisory Board*

Former VP, Global Research, Zimmer Biomet, 30 years medical device product development

**Steven R. Buchman**, MD
*CMF Medical Advisory Board*

Tenured Professor of Surgery in the Section of Plastic and Reconstructive Surgery; holds a joint appointment as a Professor of Neurosurgery at the University of Michigan Medical School; Director of the Craniofacial Anomalies Program at the University of Michigan Medical Center

Kamlesh B. Patel — **Kamlesh Patel**, MD
*CMF Medical Advisory Board*

Specializing in craniofacial and plastic surgery, Dr. Patel is Assistant Professor of Surgery in the Division of Plastic and Reconstructive surgery at Washington University School of Medicine, as well as the Associate Program Director for Plastic Surgery Residency

Board of Directors

Don Urbanowicz
30 years in business development – most recently as VP Business Development at Stryker Orthopedic

Dr. Steven Goldstein
Professor Emeritus and Former Associate Chair for Research, Orthopaedic Surgery at the University of Michigan Medical School; and serial entrepreneur

Robert Carnahan, PhD
40+ years in advanced materials development – former CEO of Thixomat Inc. and Sr. VP, Science and Technology, US Gypsum Corporation, and board member of several other advanced materials companies

Kurt Riegger
25 years of extensive experience in early stage biotechnology ventures

Investment Opportunities

nanoMAG has opportunity for investors seeking to participate in the growth and development of our company. The innovative products being developed at nanoMAG are aimed at the $50 Billion and growing global market for craniomaxillofacial and orthopedic implants which could return substantial value to our investors.

Our BioMg^® alloy gives us a strong competitive advantage over other bioabsorbable metal alloys with its composition containing all natural nutrients. By using a biocompatible alloy with a properly controlled absorption rate, our implants are designed to provide temporary structural reinforcement, while avoiding complications associated with current permanent metal and resorbable polymer implants.

BioMg^® technology is designed to reduce implant procedure times, reduce long-term complications, and eliminate secondary surgeries to bring value to patients and health care providers.

If you would like more information on this attractive investment opportunity, please contact us and we will be happy to provide more information.

About nanoMAG

Policy & Compliance

Press Releases

How We Work

Management Team

CMF Medical Advisory Board

Board of Directors

Investment Opportunities

innovation in Bioabsorbable Magnesium